We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App





FDA Requires Real Patient Samples for Emergency Use Authorization of COVID-19 MDx Tests

By LabMedica International staff writers
Posted on 15 May 2020
Print article
Illustration
Illustration
The US Food and Drug Administration (FDA) now requires molecular diagnostic developers to use actual positive specimens as part of its validation process for granting Emergency Use Authorization (EUA) to COVID-19 tests.

Manufacturers of assays had so far been permitted to use contrived patient samples for their EUA submissions. However, the FDA has now updated its requirements for developers seeking EUA for COVID-19 tests and use actual positive specimens as part of the validation process.

According to the FDA’s updated requirements which have been incorporated in its molecular diagnostic template for developers, a minimum of 30 positive prospective, retrospective, or leftover patient samples should be evaluated, while frozen samples are acceptable. The results must be compared to a high-sensitivity EUA RT-PCR assay, which uses a chemical lysis step, followed by solid phase extraction of nucleic acid.

"Now that there are positive patient samples, we are shifting from use of contrived samples to supplement applications to the recommendation that actual patient samples are used for the clinical performance testing," said Timothy Stenzel, director of the FDA’s office of in vitro diagnostics and radiological health. "As a result, for molecular tests the recommendation is to make comparisons to previously authorized molecular tests in order to assess whether or not accurate performance has been established."


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
COVID-19 Rapid Test
AQ+ COVID-19 Ag Rapid Test

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.